» Articles » PMID: 8818969

A Non-radioactive PCR Enzyme-immunoassay Enables a Rapid Identification of HPV 16 and 18 in Cervical Scrapes After GP5+/6+ PCR

Overview
Journal J Med Virol
Specialty Microbiology
Date 1996 Jul 1
PMID 8818969
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

In previous studies, general primer mediated PCR (GP5+/6+ PCR) was applied successfully to detect a broad spectrum of human papillomaviruses (HPV) in cervical scrapes. In order to facilitate PCR based HPV detection and typing, a colourimetric microtitre plate based hybridisation assay was developed. The method utilised one biotinylated primer (bio-GP6+) in the GP-PCR. Biotinylated PCR products were captured on streptavidin coated microtitre plates, denaturated and hybridised to digoxigenin (DIG) labelled HPV specific internal oligo probes. The DIG labelled hybrids were detected using an enzyme immunoassay (EIA). Since HPV 16 and 18 are the most common HPV types found in cervical carcinomas, this approach was initiated for these two types. Cross-hybridisation reactions were not detected when the specificity of this PCR-EIA for HPV 16 and 18 was tested on a panel of 20 different HPV genotypes. The sensitivity of the assay was found to be between 10 and 100 HPV 16 and 18 viral genomes in a background of 100 ng cellular DNA. This was similar to the detection limit of Southern blot analysis of PCR products with radioactively labelled oligonucleotides. A group of cytomorphologically normal (n = 89) and abnormal (n = 96) cervical scrapes were composed of HPV 16 and HPV 18 positive and HPV negative scrapes. All HPV 16 and 18 positive smears were detected by PCR-EIA. These results indicate that PCR-EIA has the potential for a rapid and sensitive HPV DNA test for day-to-day routine examination of cervical scrapes.

Citing Articles

Prevalence of Human Papillomavirus Infection in Breast Cancer Cells from Thai Women.

Ngamkham J, Karalak A, Chaiwerawattana A, Sornprom A, Thanasutthichai S, Sukarayodhin S Asian Pac J Cancer Prev. 2017; 18(7):1839-1845.

PMID: 28749118 PMC: 5648388. DOI: 10.22034/APJCP.2017.18.7.1839.


Mutation analysis of genes in the EGFR pathway in Head and Neck cancer patients: implications for anti-EGFR treatment response.

Boeckx C, Weyn C, Vanden Bempt I, Deschoolmeester V, Wouters A, Specenier P BMC Res Notes. 2014; 7:337.

PMID: 24899223 PMC: 4067106. DOI: 10.1186/1756-0500-7-337.


Does human papillomavirus play a role in the development of bladder transitional cell carcinoma? A comparison of PCR and immunohistochemical analysis.

Youshya S, Purdie K, Breuer J, Proby C, Sheaf M, Oliver R J Clin Pathol. 2005; 58(2):207-10.

PMID: 15677544 PMC: 1770580. DOI: 10.1136/jcp.2004.017152.


Distribution of HPV infection and tumour markers in cervical intraepithelial neoplasia from cone biopsies of Mozambican women.

Carrilho C, Cirnes L, Alberto M, Buane L, Mendes N, David L J Clin Pathol. 2004; 58(1):61-8.

PMID: 15623485 PMC: 1770547. DOI: 10.1136/jcp.2004.020552.


Comparison of three commercially available peptide-based immunoglobulin G (IgG) and IgA assays to microimmunofluorescence assay for detection of Chlamydia trachomatis antibodies.

Morre S, Munk C, Persson K, Kruger-Kjaer S, van Dijk R, Meijer C J Clin Microbiol. 2002; 40(2):584-7.

PMID: 11825974 PMC: 153365. DOI: 10.1128/JCM.40.2.584-587.2002.